A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacodynamics for the Treatment of COVID-19.
Clinical trial NCT04847544 · COMPLETED
Trial details
- NCT number
- NCT04847544
- Sponsor
- Aldeyra Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-31
- Primary completion
- 2021-10-15
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.